Combined HDAC and BET inhibition enhances melanoma vaccine immunogenicity and efficacy

Combined HDAC and BET inhibition enhances melanoma vaccine immunogenicity and efficacy

The combined inhibition of histone deacetylases (HDAC) and the proteins of the bromodomain and extraterminal (BET) family have recently shown therapeutic efficacy against melanoma, pancreatic ductal adenocarcinoma, testicular, and lymphoma cancers in murine studies. However, in such studies, the rol...

Bibliografski detalji
Glavni autori:	Badamchi-Zadeh, A, Moynihan, K, Larocca, R, Aid, M, Provine, N, Iampietro, M, Kinnear, E, Penaloza-Macmaster, P, Abbink, P, Blass, E, Tregoning, J, Irvine, D, Barouch, D
Format:	Journal article
Jezik:	English
Izdano:	American Association of Immunologists 2018

Slični predmeti

Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy
od: Badamchi-Zadeh, Alexander, i dr.
Izdano: (2020)

Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4(+) T cell responses that impair CD8(+) T cell function
od: Larocca, R, i dr.
Izdano: (2016)

Immunogenicity and cross-reactivity of rhesus adenoviral vectors
od: Iampietro, M, i dr.
Izdano: (2018)

Immediate dysfunction of vaccine-elicited CD8+ T cells primed in the absence of CD4+ T cells
od: Provine, N, i dr.
Izdano: (2016)

Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization
od: Penaloza-MacMaster, P, i dr.
Izdano: (2016)

Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
od: López-Camacho, C, i dr.
Izdano: (2019)

Novel concepts for HIV vaccine vector design
od: Alayo, Q, i dr.
Izdano: (2017)

Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
od: Wendy Mao, i dr.
Izdano: (2019-10-01)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
od: César López-Camacho, i dr.
Izdano: (2019-11-01)

Adenovirus vector and mRNA vaccines: mechanisms regulating their immunogenicity
od: Provine, NM, i dr.
Izdano: (2022)

A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma
od: Matthew J. Kling, i dr.
Izdano: (2022-11-01)

Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines
od: Alexander S. Hölscher, i dr.
Izdano: (2018-01-01)

The role of BET attenuation in melanoma
od: Henderson, EK
Izdano: (2020)

The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity
od: Liu, G, i dr.
Izdano: (2023)

Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens
od: Penaloza MacMaster, P, i dr.
Izdano: (2016)

Development of replication-competent adenovirus based vaccine vectors
od: Abbink P, i dr.
Izdano: (2012-09-01)

Adenovirus vectors from various serotypes induce distinct cytokine profiles
od: Teigler JE, i dr.
Izdano: (2012-09-01)

Combination BET Family Protein and HDAC Inhibition Synergistically Elicits Chondrosarcoma Cell Apoptosis Through RAD51-Related DNA Damage Repair
od: Huan S, i dr.
Izdano: (2020-06-01)

THE IMPACT OF THE BETTING INDUSTRY ON SPORTS
od: Ioan TURCU, i dr.
Izdano: (2020-12-01)

The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity
od: Geng Liu, i dr.
Izdano: (2023-01-01)

High-Yield Production of the Major Birch Pollen Allergen Bet v 1 With Allergen Immunogenicity in Nicotiana benthamiana
od: Yuki Yamada, i dr.
Izdano: (2020-04-01)

Adjuvanted influenza vaccines
od: John S. Tregoning, i dr.
Izdano: (2018-03-01)

A Comparison of Red Fluorescent Proteins to Model DNA Vaccine Expression by Whole Animal In Vivo Imaging.
od: Ekaterina Kinnear, i dr.
Izdano: (2015-01-01)

What Is the BET on Solid Tumors?
od: Filippakopoulos, P
Izdano: (2018)

564 Single-cell transcriptomic analysis of immune compartments following combination immunotherapy treatment in poorly immunogenic tumors
od: Nir Hacohen, i dr.
Izdano: (2021-11-01)

DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts
od: Ashish Goyal, i dr.
Izdano: (2023-10-01)

Different memory T cell phenotypes are elicited by Ad5 and rare adenoviruses
od: Penaloza P, i dr.
Izdano: (2012-09-01)

Clinical magnetocardiography: the unshielded bet—past, present, and future
od: D. Brisinda, i dr.
Izdano: (2023-08-01)

Melanoma senescence: HDAC1 in focus.
od: Goding, C
Izdano: (2007)

Viral Hijacking of BET Proteins
od: Irene P. Chen, i dr.
Izdano: (2022-10-01)

Chemical probes and inhibitors of bromodomains outside the BET family
od: Moustakim, M, i dr.
Izdano: (2016)

Developing chemical probes for the BET bromodomains
od: Hewings, D, i dr.
Izdano: (2012)

Betting on biotech :
od: Wong, Joseph, 1973-
Izdano: (2011)

BET223/BET306 – Insect Ecology (Ekologi Serangga)
od: PPSKJ, Pusat Pengajian Sains Kajihayat
Izdano: (2024)

Determinants of problem sports betting among college students: moderating roles of betting frequency and impulsive betting tendency
od: Yawen Shen
Izdano: (2023-10-01)

Cationic liposomes bearing Bet v 1 by coiled coil-formation are hypo-allergenic and induce strong immunogenicity in mice
od: Hans Warmenhoven, i dr.
Izdano: (2023-01-01)

Bet v 1-displaying elastin-like polypeptide nanoparticles induce a strong humoral and weak CD4+ T-cell response against Bet v 1 in a murine immunogenicity model
od: Jolinde van Strien, i dr.
Izdano: (2022-10-01)

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
od: Liu J, i dr.
Izdano: (2012-09-01)

Immunogenicity and efficacy of Zika virus envelope domain III in DNA, protein, and ChAdOx1 adenoviral-vectored vaccines
od: López-Camacho, C, i dr.
Izdano: (2020)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
od: Elizabeth A. Thomas
Izdano: (2014-05-01)